ADAR-RNA Trademark

Trademark Overview


On Tuesday, April 9, 2019, a trademark application was filed for ADAR-RNA with the United States Patent and Trademark Office. The USPTO has given the ADAR-RNA trademark a serial number of 88377984. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, January 6, 2020. This trademark is owned by EDIGENE INC. The ADAR-RNA trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Cell culture reagents for scientific and research use; Cells for scientific, laboratory or medical research; Reagents for scientific or medical research use; Assays and reagents for use in genetic research; Diagnostic reagents for scientific use

Cells for medical or clinical use; Pharmaceutical preparations in the nature of genetically modified therapeutic pharmaceuticals for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological, hematologic and viral diseases and disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; Pharmaceutical preparations in the nature of genetically modified therapeutic pharmaceuticals, namely, antifungal preparations, dermatological preparations, smoking cessation preparations and tissue repair preparations in the nature of biological tissue grafts; Diagnostic reagents for medicinal use

Medical and scientific research in the field of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; Medical and scientific research information in the field of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; Pharmaceutical research and development; Pharmaceutical research services; Providing medical and scientific research information in the fields of pharmaceuticals and genetics
adar-rna

General Information


Serial Number88377984
Word MarkADAR-RNA
Filing DateTuesday, April 9, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, January 6, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesCell culture reagents for scientific and research use; Cells for scientific, laboratory or medical research; Reagents for scientific or medical research use; Assays and reagents for use in genetic research; Diagnostic reagents for scientific use
Goods and ServicesCells for medical or clinical use; Pharmaceutical preparations in the nature of genetically modified therapeutic pharmaceuticals for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological, hematologic and viral diseases and disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; Pharmaceutical preparations in the nature of genetically modified therapeutic pharmaceuticals, namely, antifungal preparations, dermatological preparations, smoking cessation preparations and tissue repair preparations in the nature of biological tissue grafts; Diagnostic reagents for medicinal use
Goods and ServicesMedical and scientific research in the field of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; Medical and scientific research information in the field of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; Pharmaceutical research and development; Pharmaceutical research services; Providing medical and scientific research information in the fields of pharmaceuticals and genetics

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, April 25, 2019
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 25, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 25, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEDIGENE INC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBEIJING 102206
CN

Trademark Events


Event DateEvent Description
Monday, January 6, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, January 6, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, June 21, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 21, 2019NON-FINAL ACTION E-MAILED
Friday, June 21, 2019NON-FINAL ACTION WRITTEN
Wednesday, June 19, 2019ASSIGNED TO EXAMINER
Thursday, April 25, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, April 12, 2019NEW APPLICATION ENTERED IN TRAM